c-Kit is not expressed in malignant mesothelioma (Q38451233)

3 September 2017

c-Kit is not expressed in malignant mesothelioma (English)

1 reference

3 September 2017

Andrew E Horvai

1

1 reference

3 September 2017

Li Li

2

1 reference

3 September 2017

Zhidong Xu

3

1 reference

3 September 2017

Miranda J Kramer

4

1 reference

3 September 2017

David M Jablons

5

1 reference

3 September 2017

Patrick A Treseler

6

1 reference

3 September 2017

1 August 2003

1 reference

3 September 2017

1 reference

3 September 2017

16

1 reference

3 September 2017

8

1 reference

3 September 2017

818-822

1 reference

https://scigraph.springernature.com/pub.10.1097/01.mp.0000083647.69123.5c

3 September 2017

0 references

cites work

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Activating c-kit gene mutations in human germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

Differential expression of the c-kit proto-oncogene in germ cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MP.0000083647.69123.5C

10.1097/01.MP.0000083647.69123.5C

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference